{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Limitation of the trial is small numbers of subjects, since it is a Phase 2 clinical trial.\n\nSmall sample size may have reduced the ability to observe statistically significant treatment effects on secondary myelopreservation measures (i.e. occurrence of FN AEs, infections and antibiotics usage)."},"pointOfContact":{"email":"clinicalinfo@g1therapeutics.com","organization":"G1 Therapeutics, Inc.","phone":"919-213-9835","title":"Clinical Trial Info."}}